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Cytoplasmic free [Ca2+], [Ca2+]i, was measured in human platelets using the intracellularly-trapped, 
fluorescent indicator quin2. Basal [Ca2+]i with the Ca2+ -ronophore ionomycin revealed apparent thres- 
holds for shape-change, 5-HT release and aggregation of approx. 0.5 PM, 0.8 PM and 2 PM. Thrombin 
raised [Ca2+li to 3 PM fast enough for the Ca 2+ to have triggered the cell activation. However, thrombin 
released more S-HT than ionomycin could, and in Ca 2+-free medium thrombin evoked shape-change and 
secretion even when [Ca2+] i remained near basal levels throughout, suggesting the existence of alternative 
triggers for shape-change and secretory exocytosis. 
Platelet Calcium Fluorescent indicator 
1. INTRODUCTION 
A rise in cytoplasmic free [Ca*+], [Ca*+]i, has 
been regarded as the final common pathway for 
the cytoskeletal rearrangement of platelet shape 
change, the secretion of granule contents and ag- 
gregation [l-4], though the evidence is largely in- 
direct. Ca-ionophores can produce shape-change, 
secretion and aggregation (e.g., [4,5]) and micro- 
molar [Ca*+] can cause secretion from platelets 
made permeable to Ca buffers by high voltage dis- 
charge [6,7], but actual measurements of [Ca*+]i 
have not been previously achieved in such small 
cells. Here, we report measurements of [Ca*+]i in 
human platelets, made with a new fluorescent in- 
dicator, quin2 [8,9] that can be trapped in the 
cytoplasm of populations of intact cells of any size. 
Responses to the Ca-ionophore ionomycin [5,10], 
were compared with those to the natural agonist 
thrombin in order to: 
(9 
(ii) 
Reveal approximate [Ca* + ] thresholds for 
shape-change, secretion and aggregation; 
Examine the [Ca*+]i changes evoked by 
thrombin; 
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Shape-change Secretion 
(iii) Assess how far thrombin 
in [Ca*+], 
The most syriking finding 
Aggregation 
acts via elevation 
was that conditions 
could be found where thrombin activated the cells 
at or near basal [Ca*+]i, and even without any rise 
in [Ca*+]i. 
2. EXPERIMENTAL 
Platelets were separated from freshly drawn, ci- 
trated plasma on a Sepharose 2B column equili- 
brated with: 145 mM NaCl, 5 mM KCl, 1 mM 
MgS04, 0.5 mM Na2HP04, 10 mM Hepes, 5 mM 
glucose, pH 7.55 at room temperature (pH 7.4 at 
37°C). The gel-filtered platelets were incubated for 
25 min at 37°C with 5 PM quin2 acetyoxymethyl 
ester, which permeates the cell membrane and is 
hydrolysed to regenerate and trap the hydrophilic 
quin2. The quin2 content was -1 mmol/cell. The 
suspension was again gel-filtered to remove any 
extraneous dye, and the external [Ca*+] restored 
to 1 mM. Fluorescence was recorded at 37°C in a 
Perkin Elmer 44A fluorimeter. Quin2 shows a - 6- 
fold fluorescence nhancement on binding Ca*+, 
the binding being 1: 1, and the apparent Kd 
115 nM (with 130 mM K+, 20 mM Na+, 1 mM 
free Mg*+, pH 7.05) [9]. The [Caz+]i calibration 
procedure is detailed in [8,9]. The basic idea is to 
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release the trapped quin2 into the medium at the 
end of the experiment and record the signal at 
known [Ca*+]. The available evidence showed 
that as in lymphocytes [9] quin2 is very largely free 
in, and confined to, the cytoplasm and hence 
reports cytoplasmic (Cal+ 1. Digitonin (50 PM), 
which disrupts plasma membrane while leaving 
mitochondria largely intact, released all the dye in- 
dicating that there is no accumulation in these 
organelles. Nor did dye seem to get into secretory 
granules since thrombin-evoked discharge of gran- 
ule contents did not release the intracellular quin2. 
Shape-change and aggregation were assessed by 
a standard turbidimetric technique [ll] at 37°C 
stirring at 1100 rev./min. The fluorimeter cuvette 
was stirred only intermittently so the platelets did 
not aggregate and correlation between [Ca*+]i 
measurement and aggregation responses is offered 
with caution. However, shape-change occurs with 
or without continuous stirring and correlations 
here should be valid. Release of 5-HT was mea- 
sured in the fluorimeter cuvette simultaneously 
with quin2 fluorescence. Cells were loaded with 
1.7 PM t4C-labelled 5-HT (Amersham) along with 
the quin2. Imipramine (2 PM) was added just prior 
to stimulation to prevent re-uptake of secreted 5- 
HT. Triplicate 100~1 aliquots were taken into ice- 
cold microtubes and immediately centrifuged at 
14 000 x g for 40 s, and supernatant 14C measured 
by scintillation counting. 
3. RESULTS AND DISCUSSION 
Fig.1 shows aggregometer and fluorescence re- 
sponses to thrombin and ionomycin with 1 mM ex- 
ternal [Ca*+], [Ca*+],. A fully activating concen- 
tration of thrombin evoked a rise in [Ca*+]i from 
the basal level near 100 nM to - 3 PM, fast enough 
to have triggered the shape-change and aggrega- 
tion. Fig.lB shows that 50 nM ionomycin pro- 
duced a very similar rise in [Ca2+ ]i and also gave 
shape-change and substantial aggregation. Since 
the only significant action of ionomycin should be 
to translocate Ca*+, it seems that the elevation of 
[Ca*+]i t0 - 3 PM could largely account for the 
thrombin-evoked aggregometer responses. Also 
shown are responses to lower concentrations of 
ionomycin. 20 nM ionomycin raised [Ca2+]i to 
- 800 nM and produced shape-change but no ag- 
gregation and 10 nM ionomycin raised [Caz+]i to 
22 
-500 nM and neither aggregation nor shape- 
change. A series of experiments of this type in 
platelets from several subjects indicated threshold 
for shape-change around 400-600 nM [Ca* + Ii. 
For ionomycin to promote aggregation, a [Ca*+]; 
of -2 PM seemed to be required. This range of 
[Ca*+]; is similar to the [Ca*+] levels required to 
stimulate myosin light-chain phosphorylation in 
digitonin-treated platelets [ 121. 
The rises in [Ca*+]i could be due to Ca*+ influx 
or internal release, and to assess this the agonists 
were applied with very low external ]Ca2+] 
(- 50 nM) to minimise or eliminate influx. Fig.2a 
shows that thrombin and ionomycin (50 nM) now 
gave rapid elevation of [Ca*+]; to 200-300 nM 
demonstrating an internally releasable pool, but 
showing that at normal [Ca2+10 (1 mM) most of 
the much larger response was due to triggered in- 
flux. Both agonists seemed to release the same 
Ca2+ pool since application of one after the other 
showed virtual occlusion of the fluorescence re- 
sponse (e.g., tig.2b and 3e). A Ca2+-ionophore is 
expected to transport Cal+ out of Ca-sequestering 
organelles such as dense tubular system. It has 
been suggested that thrombin might act via throm- 
boxane A2 [3] and we find that inhibiting throm- 
boxane production with indomethicin or aspirin 
partially blocks this response to thrombin. (As we 
have discussed in [9] the presence of quin2 will 
reduce [Ca*+]; transients produced by internal re- 
lease. The [Ca*+]; reached inside unloaded cells in 
low [Ca*+] solution, would be higher than the 
200-300 nM seen here, and from the aggregome- 
ter responses we guess the peak [Ca*+]i is 
- 500 nM.) 
The striking feature of experiments like those 
shown in tig.2a is that although ionomycin expec- 
tedly fails to activate the cells with [Ca2+ ]i rising 
to only 200-300 nM, thrombin gives shape-change 
and partial aggregation. The possibility that 
ionomycin exerts inhibitory effects seems unlikely 
since subsequent application of thrombin still pro- 
duces the cellular responses. Fig.2b shows that 
thrombin could evoke the aggregometer responses 
of shape-change even while [Cal+]i remained be- 
low the normal basal level. These cells had been 
kept in Ca-free solution to deplete cellular Ca*+ 
and EGTA was added to chelate contaminating 
Ca2+. Ionomycin raised [Ca*+]i from 60-90 nM, 
showing there was still internally releasable Ca2+, 
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Fig.1. Quin2 fluorescence (upper trace) and aggregometer (lower trace) responses with 1 mM external Ca2+, (a) to 
0.4 units/ml human thrombin (Sigma) and (b) to different levels of ionomycin (Squibb) added from 10 PM DMSO 
stock, as indicated. The appropriate [Ca*+]i calibration scale is shown at the right of the fluorescence records. Excita- 
tion was at 339 nm and emission at 500 nm. Gaps in the fluorescence record show periods for addition or stirring. 
but evoked no aggregometer response. Addition of 
thrombin now gave no significant change in 
[Ca*+]i but did stimulate shape-change. These 
findings suggest that thrombin can activate shape- 
change by Ca-independent pathways, or possibly 
by increasing the Ca-sensitivity of rate-limiting 
steps. 
Fig.3 shows a similar experimental analysis of 5- 
HT secretion and [Ca*+ Ii. Panels a-c show corre- 
sponding [Ca*+]; rises and 5-HT release in re- 
sponse to ionomycin. A peak [Ca*+]i of 700 nM 
gave no release, 1.5 PM gave 40% and - 3 PM 68% 
release. These results are representative of 25 trials 
in cells from 3 subjects, which suggest an apparent 
(Ca*+]i threshold of 0.7-l PM for ionophore stim- 
ulated secretion, with substantial release at 3 PM. 
These data would fit reasonably well on the 
[Ca*+]/secretion relation seen in platelets made 
permeable to Ca-buffers by high-voltage discharge 
[6,7]. In 1 mM Ca solution, our usual dose of 
thrombin, 0.4 units/ml, produced faster and more 
substantial 5-HT release, 90% by 15 s, than did 
50 nM ionomycin, although the [Ca*+]i rises were 
similar. Thrombin could also stimulate release at 
[Ca*+] levels that were ineffective when produced 
by ionomycin. Fig.3e shows the response at 1 mM 
[Ca*+10 to a bath of thrombin of reduced potency. 
[Ca*+]; rose to only 420 nM, but there was still 
90% release. Even at very low [Ca*+],, as in fig.3d, 
with [Ca*+]i reaching only 250 nM there was still 
70% release. In 8 such tests the stimulated [Ca*+]i 
was 200 f 22 (SE) nM with 65 + 6 (SE) % release. 
By contrast, as shown in panel f, ionomycin pro- 
duces no secretion from cells in low [Ca*+lo. But 
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Fig.2. Fluorescence (upper traces) and aggregometer responses to 0.4 units/ml thrombin and 50 nM ionomycin in very 
low external [Ca*+]: (a) 2 mM EGTA was added (with 2 mM Tris base to prevent acidification) to reduce [Ca*+], to 
50 nM; (b) platelets were kept in nominally Ca-free solution throughout. 1 mM EGTA was added as indicated to 
chelate contaminating Ca2+. 
subsequent addition of thrombin evoked 70% re- intact platelets, but it seems that, as with shape- 
lease without further changing the [Ca*+]i. These change, thrombin may be additionally able to trig- 
findings show that [Ca*+]i in the micromolar ger secretory exocytosis by as yet unidentified Ca- 
range is an effective stimulus for 5-HT secretion in independent pathways. 
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Fig.3. [Caz+]i and S-HT secretion expressed as 8 release of 5-[14C]HT in the cells just prior to stimulation (a) 35 nM 
ionomycin added; (b,c) 50 nM ionomycin with 1 mM [Ca2+10 (The different [Ca2+]i transients and secretions in (b,c) 
probably result from the difficulty in precisely matching application of hydrophobic reagents, and the apparent steep- 
ness of the ionomycin dose-response relation in this region); (d,e) responses to thrombin in very low, and normal 
[Ca2+],; (f) shows responses first to 50 nM ionomycin and then 0.4 units/ml thrombin with [Ca2+10 lowered to 50 nM. 
The dotted lines are drawn for guidance only. 
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